Are antimicrobial stewardship programs effective strategies for preventing antibiotic resistance? A systematic review
Carregando...
Citações na Scopus
40
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
MOSBY-ELSEVIER
Citação
AMERICAN JOURNAL OF INFECTION CONTROL, v.46, n.7, p.824-836, 2018
Resumo
Background: Antimicrobial stewardship programs (ASPs) have been proposed as a solution for the global burden of antibiotic resistance, despite the lack of evidence on the subject. Objective: To analyze the role of ASPs in reducing bacterial resistance to antibiotics in hospital settings. Data sources: A review in PubMed, Scopus, LILACS, and SciELO databases was performed. The period analyzed was January 1, 2012-January 4, 2017. Eligibility criteria: Studies that related ASPs to bacterial resistance. Data extraction: All studies that did not focus on ASPs were removed. Antifungal and antiviral programs were excluded. Results: Only 8 studies had quasi-experimental designs, and none were controlled trials. ASP strategies and microorganism-antibiotic pairs evaluated varied widely. Seven studies were classified as presenting clearly positive results, 3 had limited positive results, 7 had doubtful results, 4 had negative results, and 5 had noninterpretable results. The implementation of new infection control practices occurred in 7 studies. Limitations: There are yet few studies on this matter, and most of them have inadequate study designs. Great heterogeneity between study features was detrimental to drawing evidence-based conclusions. Conclusions: There is no solid evidence that ASPs are effective in reducing antibiotic resistance in hospital settings. We uphold the need for more studies with appropriate study designs, standardized ASP interventions targeting common microorganism-antibiotic pairs, and avoiding simultaneous implementation of infection control practices.
Palavras-chave
Antimicrobial stewardship, infection control, antibiotic resistance, bacterial, review, systematic
Referências
- Agwu AL, 2008, CLIN INFECT DIS, V47, P747, DOI 10.1086/591133
- Alawi MM, 2016, SAUDI MED J, V37, P1350, DOI 10.15537/smj.2016.12.15739
- Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167
- Bartlett JG, 2013, CLIN INFECT DIS, V56, P1445, DOI 10.1093/cid/cit070
- Bedini A, 2016, DIGEST LIVER DIS, V48, P1142, DOI 10.1016/j.dld.2016.06.023
- Burke JP, 1998, JAMA-J AM MED ASSOC, V280, P1270, DOI 10.1001/jama.280.14.1270
- Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7
- Cassier P, 2011, CLIN MICROBIOL INFEC, V17, P1746, DOI 10.1111/j.1469-0691.2010.03349.x
- Centers for Disease Control and Prevention, 2013, OFF INF DIS ANT RES
- Chan YY, 2011, INT J ANTIMICROB AG, V38, P486, DOI 10.1016/j.ijantimicag.2011.08.011
- Chen CH, 2015, MED MALADIES INFECT, V45, P264, DOI 10.1016/j.medmal.2015.04.005
- Cook PP, 2015, INT J ANTIMICROB AG, V45, P262, DOI 10.1016/j.ijantimicag.2014.11.006
- Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096
- Dancer SJ, 2013, INT J ANTIMICROB AG, V41, P137, DOI 10.1016/j.ijantimicag.2012.10.013
- Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3
- de Kraker MEA, 2017, CLIN MICROBIOL INFEC, V23, P819, DOI 10.1016/j.cmi.2017.05.019
- del Arco A, 2015, EUR J CLIN MICROBIOL, V34, P247, DOI 10.1007/s10096-014-2225-5
- Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393
- DiazGranados CA, 2012, AM J INFECT CONTROL, V40, P526, DOI 10.1016/j.ajic.2011.07.011
- Doernberg SB, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0095-y
- Effective Practice and Organization of Care, 2015, EPOC RES REV AUTH
- Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0
- Guo W, 2015, AM J INFECT CONTROL, V43, P358, DOI 10.1016/j.ajic.2014.12.010
- Hou DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101447
- Jenkins TC, 2015, INFECT CONT HOSP EP, V36, P664, DOI 10.1017/ice.2015.41
- Kim YC, 2013, AM J INFECT CONTROL, V41, pE39, DOI 10.1016/j.ajic.2012.12.018
- Knudsen JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084910
- Lai CC, 2016, J MICROBIOL IMMUNOL, V49, P74, DOI 10.1016/j.jmii.2015.05.011
- Lawes T, 2015, LANCET INFECT DIS, V15, P1438, DOI 10.1016/S1473-3099(15)00315-1
- Lew KY, 2015, J ANTIMICROB CHEMOTH, V70, P1219, DOI 10.1093/jac/dku479
- Liew YX, 2012, INT J ANTIMICROB AG, V40, P55, DOI 10.1016/j.ijantimicag.2012.03.004
- Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656
- MacDougall C, 2005, CLIN MICROBIOL REV, V18, P638, DOI 10.1128/CMR.18.4.638-656.2005
- Malani AN, 2013, AM J INFECT CONTROL, V41, P145, DOI 10.1016/j.ajic.2012.02.021
- Morrill HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150795
- Munita JM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0016-2015
- Nijssen S, 2006, CLIN INFECT DIS, V43, P616, DOI 10.1086/506438
- Niwa T, 2012, INT J CLIN PRACT, V66, P999, DOI 10.1111/j.1742-1241.2012.02999.x
- Nowak MA, 2012, AM J HEALTH-SYST PH, V69, P1500, DOI 10.2146/ajhp110603
- O'Brien KA, 2015, PHARMACOTHERAPY, V35, P464, DOI 10.1002/phar.1590
- Okumura LM, 2015, BRAZ J INFECT DIS, V19, P246, DOI 10.1016/j.bjid.2015.02.005
- Sarma JB, 2015, J HOSP INFECT, V91, P68, DOI 10.1016/j.jhin.2015.05.006
- Schechner V, 2013, CLIN MICROBIOL REV, V26, P289, DOI 10.1128/CMR.00001-13
- Taggart LR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1223-2
- Viale P, 2015, CLIN MICROBIOL INFEC, V21, P242, DOI 10.1016/j.cmi.2014.10.020
- Wong D, 2017, VIRULENCE, V8, P383, DOI 10.1080/21505594.2016.1188234
- World Health Organization, 2014, ANT RES GLOB REP SUR
- Yoon Y., 2014, MICRONANOSYST LETT, V2, P1, DOI 10.1186/S40486-014-0003-X)
- Zou YM, 2015, EUR J CLIN MICROBIOL, V34, P795, DOI 10.1007/s10096-014-2293-6